1
0
0
(1 - 28 von 31
)
Биологические особенности трансформации плазматических клеток и...
medical-diss.com
Multiple myeloma / Marc S. Raab, Klaus Podar, Iris Breitkreutz, Paul G. Richardson, Kenneth C. Anderson // Lancet Vol P Hernandez, L. Palomera, D. Carrera, R. Martinez, J. De la Rubia, A. Martin, J. Blade, J J. Lahuerta, A. Orfao, J.F. San Miguel // Blood №10. -Vol P
Ludmila Weiz | 5 Publications | Citations | Related Authors
typeset.io
Abstract: // Verena Wagner 1,* , Dirk Hose 2,3,* , Anja Seckinger 2 , Ludmila Weiz 1 , Tobias Meisner 2 , Thiery Reme 4 , Iris Breitkreutz 1,3 , Klaus Podar ... › authors
Big tranSMART for Clinical Decision Making - Spiral
spiral.imperial.ac.uk
[RPB+09] Marc S Raab, Klaus Podar, Iris Breitkreutz, Paul G Richardson, and Ken- neth C Anderson. Multiple myeloma. Lancet, 374:324–339, › bitstream › Wang-S-...
Suppressing miRNA-15a/-16 expression by interleukin-6 enhances...
jhoonline.biomedcentral.com
Raab MarcS, Klaus Podar, Iris Breitkreutz: Multiple myeloma. Lancet 2009, 374: PubMed Abstract | Publisher Full Text. Hardin J, MacLeod S, Grigorieva I, Chang
Suppressing miRNA-15a/-16 expression by interleukin-6 enhances...
link.springer.com
Journal of Hematology & Oncology , 2: CrossRefGoogle Scholar. 6. Raab Marc, Klaus Podar, Iris Breitkreutz: ...
The orally available multikinase inhibitor regorafenib (BAY )...
link.springer.com
Iris Breitkreutz; Klaus Podar; Vianihuini Figueroa-Vazquez; Scott Wilhelm; Patrick J. Hayden; Kenneth C. Anderson; Marc S. RaabEmail author. Iris Breitkreutz.
HEIDI: Breitkreutz, Iris: The orally available multikinase inhibitor ...
www.bing.com
NettetIris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, Scott Wilhelm, Patrick J. Hayden, Kenneth C. Anderson, Marc S. Raab: E-Jahr: 2018: Jahr: 23 January 2018: …
Iris Breitkreutz
www.infona.pl
Search results for: Iris Breitkreutz ... Marc S Raab, Klaus Podar, Iris Breitkreutz, Paul G Richardson, more · The Lancet > > 374 > > Multiple ...
Dose-intensified bendamustine followed by autologous ...
pubmed.ncbi.nlm.nih.gov
von I Breitkreutz · · Zitiert von: 4 — Iris Breitkreutz , Natalia Becker , Axel Benner , Florentina Kosely , Christoph Heining , Jens Hillengass , Gerlinde Egerer , Anthony D Ho , Hartmut ... von I Breitkreutz · · Zitiert von: 8 — Iris Breitkreutz , Klaus Podar , Vianihuini Figueroa-Vazquez , Scott Wilhelm , Patrick J Hayden , Kenneth C Anderson , Marc S Raab ... › ...
Multiple myeloma.Read by QxMD
read.qxmd.com
Marc S Raab, Klaus Podar, Iris Breitkreutz, Paul G Richardson, Kenneth C Anderson. Lancet July 26. Multiple myeloma is characterised by clonal ...
Preclinical efficacy of sepantronium bromide (YM155) in ...Europe PMC
europepmc.org
von V Wagner · · Zitiert von: 42 — Verena Wagner,#1 Dirk Hose,#2,3 Anja Seckinger,2 Ludmila Weiz,1 Tobias Meißner,2 Thiery Rème,4Iris Breitkreutz,1,3 Klaus Podar,3 Anthony D. Ho,2 Hartmut ...
Preclinical efficacy of sepantronium bromide (YM155) in ...Oncotarget
www.oncotarget.com
von V Wagner · · Zitiert von: 41 — ... Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreutz, Klaus Podar, Anthony D. Ho, Hartmut Goldschmidt, Alwin...
Dr. Scott Wilhelm, MD – Cleveland, OH | General Surgery
www.doximity.com
Iris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, Scott Wilhelm, Patrick Hayden, Kenneth C. Anderson, Marc-Steffen Raab> ;Annals of Hematology. › pub
Publications - DTU ChemistryDTU Kemi
www.kemi.dtu.dk
Raab, Iris Breitkreutz, Simon Anderhub, Mads H. Rønnest, Blanka Leber, Thomas O. Larsen, Ludmila Weiz, Gleb Konotop, Patrick J. Hayden, Klaus Podar, Johannes ...
Targeting PKC in multiple myeloma: in vitro and in vivo ...Altmetric
www.altmetric.com
Klaus Podar, Marc S. Raab, Jing Zhang, Douglas McMillin, Iris Breitkreutz, Yu-Tzu Tai, Boris K. Lin, Nikhil Munshi, Teru Hideshima, Dharminder Chauhan, ...
Suppressing miRNA-15a/-16 expression by CyberLeninkacyberleninka.org › article
cyberleninka.org
Raab SMarc, Klaus Podar, Iris Breitkreutz: Multiple myeloma. Lancet 2009, 374: Hardin J, MacLeod S, Grigorieva I, Chang R, Barlogie B, Xiao H, ...
Karlsruher Virtueller Katalog KVKKarlsruhe Institute of Technology ·
kvk.bibliothek.kit.edu
The orally available multikinase inhibitor regorafenib (BAY ) in multiple myeloma / by Iris Breitkreutz, Klaus Podar, Vianihuini Figueroa-Vazquez, ... › ...
Preclinical efficacy of sepantronium bromide (YM155) in multiple...
www.oncotarget.com
https://doi.org oncotarget Verena Wagner, Dirk Hose, Anja Seckinger, Ludmila Weiz, Tobias Meißner, Thiery Rème, Iris Breitkreutz, Klaus Podar,...
Resultados de búsqueda - "Irene Ghobrial"
buscador.una.edu.ni
Autores: Marc S. Raab, Klaus Podar, Jing Zhang, Douglas McMillin, Iris Breitkreutz, Yu-Tzu Tai, Boris Lin, Irene Ghobrial, Nikhil Munshi, Teru Hideshima, ... › Search
Targeting PKC in multiple myeloma: in vitro and in vivo effects ...medchemexpress.cn ·
www.medchemexpress.cn
Klaus Podar 1, Marc S Raab, Jing Zhang, Douglas McMillin, Iris Breitkreutz, Yu-Tzu Tai, Boris K Lin, Nikhil Munshi, Teru Hideshima, Dharminder Chauhan, ... › ...
The malignant clone and the bone-marrow environmentQxMD ·
read.qxmd.com
Yu-Tzu Tai, Xian-Feng Li, Iris Breitkreutz, Weihua Song, Paola Neri, Laurence Catley, Klaus Podar, Teru Hideshima, Dharminder Chauhan, Noopur Raje, ... Marc S Raab, Klaus Podar, Iris Breitkreutz, Paul G Richardson, Kenneth C Anderson. Lancet July 25, 374 (9686): › t... › ...
[PDF] 13ab4e70d3fb9fc861c2f4ea pdfs.semanticscholar.org › ...
www.semanticscholar.org
· Yu-Tzu Tai,1 Xian-Feng Li,1 Laurence Catley,1 Rory Coffey,1 Iris Breitkreutz,1. Jooeun Bae,1 Weihua Song,1 Klaus Podar,1 Teru Hideshima,1.
Alle Infos zum Namen "Iris Breitkreutz"
Verwandte Suchanfragen zu Iris Breitkreutz
| Thomas Hielscher Blanka Leber Hartmut Goldschmidt | Karin Jordan Klaus Podar Jens Hillengass | Douglas McMillin Natalia Becker Gerlinde Egerer |
Personen Vorname "Iris" (22276) Name "Breitkreutz" (181) |
sortiert nach Relevanz / Datum